Trijardy XR Interactions
There are 547 drugs known to interact with Trijardy XR (empagliflozin/linagliptin/metformin), along with 9 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 26 are major, 513 are moderate, and 8 are minor.
- View all 547 medications that may interact with Trijardy XR
- View Trijardy XR alcohol/food interactions (3)
- View Trijardy XR disease interactions (9)
Most frequently checked interactions
View interaction reports for Trijardy XR (empagliflozin / linagliptin / metformin) and the medicines listed below.
- amlodipine
- aspirin
- atorvastatin
- carvedilol
- clonazepam
- clopidogrel
- duloxetine
- Eliquis (apixaban)
- ezetimibe
- famotidine
- fenofibrate
- gabapentin
- glimepiride
- glipizide
- hydrochlorothiazide
- Jardiance (empagliflozin)
- levothyroxine
- lisinopril
- losartan
- metformin
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- montelukast
- omeprazole
- Ozempic (semaglutide)
- pantoprazole
- rosuvastatin
- tamsulosin
- tizanidine
- Vitamin D3 (cholecalciferol)
Trijardy XR alcohol/food interactions
There are 3 alcohol/food interactions with Trijardy XR (empagliflozin / linagliptin / metformin).
Trijardy XR disease interactions
There are 9 disease interactions with Trijardy XR (empagliflozin / linagliptin / metformin) which include:
- pancreatitis
- lactic acidosis
- liver disease
- renal dysfunction
- renal dysfunction
- hypoglycemia
- B12 deficiency
- hypotension
- infections
More about Trijardy XR (empagliflozin / linagliptin / metformin)
- Trijardy XR consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.